United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60760-658_5851bb67-e46f-2b1b-e063-6394a90a6a56
- Product NDC
- 60760-658
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- St. Mary's Medical Park Pharmacy
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230620
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-658-10) · 60760-658-10
- 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-658-15) · 60760-658-15
- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-658-20) · 60760-658-20
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-658-60) · 60760-658-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →